GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Short Percentage of Float

Simris Alg AB (OSTO:SIMRIS B) Short Percentage of Float


View and export this data going back to 2016. Start your Free Trial

What is Simris Alg AB Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Simris Alg AB's Short Percentage of Float

For the Biotechnology subindustry, Simris Alg AB's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Simris Alg AB's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Simris Alg AB's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Simris Alg AB's Short Percentage of Float falls into.


Simris Alg AB (OSTO:SIMRIS B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Short Percentage of Float
Comparable Companies
OSTO:ZICC OSTO:LIPUM NGM:GTAB B OSTO:ACE XSAT:CESSA OSTO:XINT XSAT:WNT OSTO:NXTCL XSAT:DEX OSTO:BIOVIC B OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5LU:Germany
Address
Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Website
https://www.simrisalg.se
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.

Simris Alg AB (OSTO:SIMRIS B) Headlines

No Headlines